3,5'-diallyl-2'-ethoxybiphenyl-4-ol

ID: ALA1829020

Chembl Id: CHEMBL1829020

PubChem CID: 54592209

Max Phase: Preclinical

Molecular Formula: C20H22O2

Molecular Weight: 294.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCc1ccc(OCC)c(-c2ccc(O)c(CC=C)c2)c1

Standard InChI:  InChI=1S/C20H22O2/c1-4-7-15-9-12-20(22-6-3)18(13-15)16-10-11-19(21)17(14-16)8-5-2/h4-5,9-14,21H,1-2,6-8H2,3H3

Standard InChI Key:  WSNYCJWIVUTQGA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA1829020

    Magreth-16a

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; GABA-A site (alpha1/beta2 interface) (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNE2Z (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

I10 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 294.39Molecular Weight (Monoisotopic): 294.1620AlogP: 4.91#Rotatable Bonds: 7
Polar Surface Area: 29.46Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.06CX Basic pKa: CX LogP: 5.71CX LogD: 5.70
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.73Np Likeness Score: 0.39

References

1. Taferner B, Schuehly W, Huefner A, Baburin I, Wiesner K, Ecker GF, Hering S..  (2011)  Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.,  54  (15): [PMID:21699169] [10.1021/jm200186n]
2. Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L..  (2011)  Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.,  54  (19): [PMID:21853991] [10.1021/jm200830u]
3. Lin D, Yan Z, Chen A, Ye J, Hu A, Liu J, Peng J, Wu X..  (2019)  Anti-proliferative activity and structure-activity relationship of honokiol derivatives.,  27  (16): [PMID:31278004] [10.1016/j.bmc.2019.06.042]
4. Zhu M, Li B, Ma H, Huang X, Wang H, Dai Y, Li Y, Li HM, Wu CZ..  (2020)  Synthesis and in vitro antitumor evaluation of honokiol derivatives.,  30  (2): [PMID:31831382] [10.1016/j.bmcl.2019.126849]

Source